Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ClpP (caseinolytic peptidase P) is a highly conserved serine protease found in bacteria, mitochondria of eukaryotic cells, and chloroplasts. In mammalian cells, it is localized to the mitochondrial matrix and forms part of the ATP-dependent ClpXP proteolytic complex. Its primary function is to maintain protein homeostasis by degrading misfolded or damaged proteins within mitochondria. It assembles into a tetradecameric complex composed of two stacked heptameric rings, creating a barrel-shaped structure. The active site contains a Ser-His-Asp catalytic triad. Degradation of larger proteins requires association with an ATP-dependent chaperone such as ClpX. Upregulation has been observed in various human tumors. Both activators and inhibitors targeting this enzyme can disrupt oxidative phosphorylation in cancer cells—inducing apoptosis—making it a potential therapeutic target for cancer treatment as well as bacterial infections.
Disruption of oxidative phosphorylation, induction of apoptosis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caseinolytic peptidase P (ClpP).